|Day Low/High||10.04 / 10.47|
|52 Wk Low/High||6.50 / 25.10|
Let's look at the chart of CRON.
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
It all comes down to matching my time frame.
Here's how to play OGI stock right now.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Charts of this type are frequently found to be topping patterns.
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Equity markets marked time on Monday, mostly on light volume.
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz's addition should pacify a persistent critique of the company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
In its first report on cannabis companies, Melius says prices are high.
The stock price of the cannabis company has been on a roll and is poised to move even higher still.
And why I won't recommend any other stocks in these markets, right now.
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.